Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dexamethasone in Patients With ARDS and COVID-19 - Prospective, Multi-centre, Open-label, Parallel-group, Randomized Controlled Trial (REMED Trial)

NCT04663555 is registered in ClinicalTrials.gov with Brno University Hospital as lead sponsor.

NCT NCT04663555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04663555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dexamethasone in Patients With ARDS and COVID-19 - Prospective, Multi-centre, Open-label, Parallel-group, Randomized Controlled Trial (REMED Trial)
Lead sponsor
Brno University Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 2, 2021
Completion date
February 23, 2023
Enrollment
235 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, covid19